LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Gaffney, Rebecca G"
  2. AU="Husmann, Douglas A"

Search results

Result 1 - 10 of total 11

Search options

  1. Article: Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab.

    Gaffney, Rebecca G / Merola, Joseph F

    JAAD case reports

    2023  Volume 44, Page(s) 71–73

    Language English
    Publishing date 2023-12-16
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2834220-3
    ISSN 2352-5126
    ISSN 2352-5126
    DOI 10.1016/j.jdcr.2023.12.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A case of paradoxical eosinophilic fasciitis in a patient on benralizumab.

    Woodbury, Michael J / Gaffney, Rebecca G / Merola, Joseph F

    JAAD case reports

    2023  Volume 40, Page(s) 45–46

    Language English
    Publishing date 2023-08-13
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2834220-3
    ISSN 2352-5126
    ISSN 2352-5126
    DOI 10.1016/j.jdcr.2023.08.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib.

    Zhang, Arianna / Gaffney, Rebecca G / Merola, Joseph F

    JAAD case reports

    2023  Volume 45, Page(s) 110–112

    Language English
    Publishing date 2023-12-16
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2834220-3
    ISSN 2352-5126
    ISSN 2352-5126
    DOI 10.1016/j.jdcr.2023.11.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures.

    Gaffney, Rebecca G / Werth, Victoria P / Merola, Joseph F

    Frontiers in medicine

    2022  Volume 9, Page(s) 968469

    Language English
    Publishing date 2022-10-14
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2022.968469
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Evaluating results of an interferon-γ release assay in patients with autoimmune disease who are taking hydroxychloroquine.

    Gaffney, Rebecca G / Werth, Victoria P

    Journal of the American Academy of Dermatology

    2018  Volume 80, Issue 4, Page(s) 1162–1164

    MeSH term(s) Adult ; Aged ; Anti-Inflammatory Agents/therapeutic use ; Antirheumatic Agents/therapeutic use ; Dermatomyositis/drug therapy ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Interferon-gamma Release Tests ; Latent Tuberculosis/diagnosis ; Lupus Erythematosus, Cutaneous/drug therapy ; Male ; Middle Aged ; Prednisone/therapeutic use
    Chemical Substances Anti-Inflammatory Agents ; Antirheumatic Agents ; Hydroxychloroquine (4QWG6N8QKH) ; Prednisone (VB0R961HZT)
    Language English
    Publishing date 2018-12-21
    Publishing country United States
    Document type Letter
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2018.12.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Drug-induced dermatomyositis after lacosamide: A case report.

    Gaffney, Rebecca G / Tarazi, Meera / Werth, Victoria P

    JAAD case reports

    2018  Volume 4, Issue 6, Page(s) 584–585

    Language English
    Publishing date 2018-06-13
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2834220-3
    ISSN 2352-5126
    ISSN 2352-5126
    DOI 10.1016/j.jdcr.2018.03.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Auditory event-related potentials and function of the medial olivocochlear efferent system in children with auditory processing disorders.

    Morlet, Thierry / Nagao, Kyoko / Greenwood, L Ashleigh / Cardinale, R Matthew / Gaffney, Rebecca G / Riegner, Tammy

    International journal of audiology

    2019  Volume 58, Issue 4, Page(s) 213–223

    Abstract: Objective: The objectives were to investigate the function of central auditory pathways and of the medial efferent olivocochlear system (MOCS).: Design: Event-related potentials (ERP) were recorded following the delivery of the stimulus /da/ in quiet ...

    Abstract Objective: The objectives were to investigate the function of central auditory pathways and of the medial efferent olivocochlear system (MOCS).
    Design: Event-related potentials (ERP) were recorded following the delivery of the stimulus /da/ in quiet and in ipsilateral, contralateral, and binaural noise conditions and correlated to the results of the auditory processing disorders (APD) diagnostic test battery. MOCS function was investigated by adding ipsilateral, contralateral, and binaural noise to transient evoked otoacoustic emission recordings. Auditory brainstem responses and pure tone audiogram were also evaluated.
    Study sample: Nineteen children (7 to 12 years old) with APD were compared with 24 age-matched controls.
    Results: Otoacoustic emissions and ABR characteristics did not differ between groups, whereas ERP latencies were significantly longer and of higher amplitudes in APD children than in controls, in both quiet and noise conditions. The MOCS suppression was higher in APD children.
    Conclusions: Findings indicate that children with APD present with neural deficiencies in both challenging and nonchallenging environments with an increase in the timing of several central auditory processes correlated to their behavioural performances. Meanwhile, their modulation of the auditory periphery under noisy conditions differs from control children with higher suppression.
    MeSH term(s) Acoustic Stimulation ; Auditory Perceptual Disorders/diagnosis ; Auditory Perceptual Disorders/physiopathology ; Auditory Perceptual Disorders/psychology ; Child ; Cochlea/innervation ; Efferent Pathways/physiopathology ; Evoked Potentials, Auditory ; Evoked Potentials, Auditory, Brain Stem ; Female ; Humans ; Male ; Noise/adverse effects ; Olivary Nucleus/physiopathology ; Otoacoustic Emissions, Spontaneous ; Perceptual Masking ; Speech Perception ; Speech Reception Threshold Test
    Language English
    Publishing date 2019-01-25
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2073098-6
    ISSN 1708-8186 ; 1499-2027
    ISSN (online) 1708-8186
    ISSN 1499-2027
    DOI 10.1080/14992027.2018.1551632
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.

    Tarazi, Meera / Gaffney, Rebecca G / Kushner, Carolyn J / Chakka, Srita / Werth, Victoria P

    Arthritis care & research

    2019  Volume 71, Issue 11, Page(s) 1404–1409

    Abstract: Objective: Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One hallmark of the disease is the presence of antinuclear antibodies (ANAs), a feature that has been incorporated into multiple ... ...

    Abstract Objective: Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One hallmark of the disease is the presence of antinuclear antibodies (ANAs), a feature that has been incorporated into multiple classification criteria over the years. In this study, we used a database of patients with cutaneous lupus erythematosus (CLE) to determine how many had a negative ANA and met criteria for SLE using the American College of Rheumatology (ACR) and/or Systemic Lupus International Collaborating Clinics (SLICC) criteria.
    Methods: We used a database of 301 biopsy-proven CLE patients that contained information including ANA status and the presence of features of SLE. The database was searched for patients who had a negative ANA result and whether or not they met SLE criteria using the ACR and/or SLICC criteria.
    Results: Of the 301 patients with biopsy-proven CLE and a known ANA, 111 had a negative ANA test (36.9%) and 27 had an ANA test that fluctuated (33.3%). In all, 20 ANA-negative patients met SLE criteria (18.0%), and 12 patients with a fluctuating ANA test met SLE criteria (44.4%). Of all patients who had either a negative or fluctuating ANA result and who met criteria for SLE (n = 32), 27 patients had involvement of ≥1 organ system other than skin (84.4%), and 13 patients had involvement of ≥2 organ systems other than skin (40.6%).
    Conclusion: Our results show that an ANA is not always present in patients with systemic disease. This fact should be taken into consideration when devising SLE classification criteria to be used for clinical trials.
    MeSH term(s) Adolescent ; Adult ; Antibodies, Antinuclear/blood ; Databases, Factual ; Diagnosis, Differential ; Female ; Humans ; International Cooperation ; Lupus Erythematosus, Cutaneous/diagnosis ; Lupus Erythematosus, Systemic/diagnosis ; Male ; Middle Aged ; Retrospective Studies ; Rheumatology/standards ; Severity of Illness Index ; Young Adult
    Chemical Substances Antibodies, Antinuclear
    Language English
    Publishing date 2019-05-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 645059-3
    ISSN 2151-4658 ; 0893-7524 ; 2151-464X
    ISSN (online) 2151-4658
    ISSN 0893-7524 ; 2151-464X
    DOI 10.1002/acr.23916
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis.

    Gaffney, Rebecca G / Feng, Rui / Pearson, David R / Tarazi, Meera / Werth, Victoria P

    Journal of the American Academy of Dermatology

    2019  Volume 80, Issue 6, Page(s) 1793–1794

    MeSH term(s) Biopsy, Needle ; Clinical Trials as Topic ; Databases, Factual ; Dermatomyositis/pathology ; Dermatomyositis/physiopathology ; Dermatomyositis/psychology ; Disease Progression ; Female ; Humans ; Immunohistochemistry ; Longitudinal Studies ; Male ; Prospective Studies ; Quality of Life ; Risk Assessment ; Severity of Illness Index
    Language English
    Publishing date 2019-01-24
    Publishing country United States
    Document type Letter
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2019.01.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.

    Krain, Rebecca L / Kushner, Carolyn J / Tarazi, Meera / Gaffney, Rebecca G / Yeguez, Andrea C / Zamalin, Danielle E / Pearson, David R / Feng, Rui / Payne, Aimee S / Werth, Victoria P

    Frontiers in immunology

    2019  Volume 10, Page(s) 2571

    Abstract: Pemphigus, an autoimmune blistering disease that affects the skin and mucous membranes, adversely impacts patients' quality of life (QOL). While there are various QOL measurement tools that can be used in this disease, few studies have assessed how a ... ...

    Abstract Pemphigus, an autoimmune blistering disease that affects the skin and mucous membranes, adversely impacts patients' quality of life (QOL). While there are various QOL measurement tools that can be used in this disease, few studies have assessed how a patient's change in disease severity can affect their QOL. This study aims to identify which disease severity index correlates best with the change in QOL. Fifty pemphigus patients completed QOL surveys with disease severity scored over two visits. QOL was assessed with the Autoimmune Bullous Disease Quality of Life (ABQOL), Dermatology Life Quality Index (DLQI), Skindex-29, and Short Form Survey 36 (SF-36). Disease severity was scored with the Pemphigus Disease Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity Score (ABSIS). Correlations between the change in QOL scores and change in disease severity were analyzed using Spearman's coefficient (
    MeSH term(s) Adult ; Aged ; Biopsy ; Disease Susceptibility ; Female ; Humans ; Male ; Middle Aged ; Patient Outcome Assessment ; Pemphigus/diagnosis ; Pemphigus/epidemiology ; Pemphigus/etiology ; Public Health Surveillance ; Quality of Life ; Severity of Illness Index ; Symptom Assessment
    Language English
    Publishing date 2019-11-06
    Publishing country Switzerland
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2019.02571
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top